Mosaic Clade M Human Immunodeficiency Virus Type 1 (hiv-1) Gag Immunogens

Abstract

The present invention relates, in general, to an immunogenic composition (e.g., a vaccine) and, in particular, to a polyvalent immunogenic composition, such as a polyvalent HIV vaccine, and to methods of using same. The invention further relates to methods that use a genetic algorithm to create sets of polyvalent antigens suitable for use, for example, in vaccination strategies.


Claims
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Dec 19, 2017
  • Application: May 29, 2015
    US US 201514726373 A
  • Priority: May 29, 2015
    US US 201514726373 A
  • Priority: Feb 1, 2012
    US US 73776112 A
  • Priority: Aug 14, 2009
    US US 2009/0004664 W
  • Priority: Apr 20, 2009
    US US 99022209 A
  • Priority: Aug 14, 2008
    US US 19201508 A
  • Priority: Aug 23, 2006
    US US 2006/0032907 W
  • Priority: Nov 25, 2005
    US US 73941305 P
  • Priority: Aug 23, 2005
    US US 71015405 P

Download Citation


Sign in to the Lens

Feedback